Evaluation Of The Clinical Benefit Obtained In Patients With Knee And/Or Hip Osteoarthritis After A Proactive Intervention On The Primary Care Physician
| ISRCTN | ISRCTN27865285 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN27865285 |
| Secondary identifying numbers | N/A |
- Submission date
- 04/02/2010
- Registration date
- 19/02/2010
- Last edited
- 22/02/2010
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Agustín Gómez de la Cámara
Scientific
Scientific
Hospital Universitario 12 de Octubre
Clinical Epidemiology Research Unit
Mother and Child Building
Basement -2
Avenida de Córdoba s/n
Madrid
28041
Spain
| acamara@h12o.es |
Study information
| Study design | Multicentre prospective cluster randomised controlled parallel group trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | GP practice |
| Study type | Not Specified |
| Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet. |
| Scientific title | Study of the clinical benefit and quality of life perception in patients with osteoarthritis of the hip and the knee. Evaluation based on a proactive follow-up intervention made by primary care physicians. Experimental open, randomized and controlled study. |
| Study acronym | ARTRO-pro_AP |
| Study objectives | Despite the availability of evidence-based guidelines for the management of asymptomatic chronic diseases such as osteoarthritis, physicians often do not initiate, intensify or optimize therapy when indicated, so that patients are not treated effectively. This phenomenon is known as clinical inertia. The main objective of this study was to evaluate whether an intervention on primary care physicians to avoid clinical inertia, could improve the perception of pain, functionality and quality of life in patients with hip and/or knee osteoarthritis (OA). |
| Ethics approval(s) | The Ethical Committee of Hospital Universitario 12 de Octubre approved on August 1st, 2007. Notification was sent to the Spanish Agency of Medicines and Health Products (Agencia Española de Medicamentos y Productos Sanitarios [AEMPS]) on November 20th, 2007. |
| Health condition(s) or problem(s) studied | Hip and Knee Arthritis |
| Intervention | Clusters of primary care physicians working at the same healthcare centre for more than 6 months were randomly assigned to 1 of 2 study groups. 1. Group 1 (Proactive Intervention): Physicians in this group received a 45-60 minute training session on the latest European League Against Rheumatism (EULAR) recommendations on OA management, therapeutic goals, motivational techniques, and the Visual Analogue Scale (VAS), Western Ontario and McMaster Universities (WOMAC) and Short Form-12 (SF-12) questionnaires. 2. Group 2 (Control): Physicians in this group received only a brief description of the study. Each physician includes the first three patients with knee and/or hip OA who fulfil the eligibility criteria. Both groups were given the same Case Report Forms. All patients were scheduled for two visits (Visit 1 and Visit 2), six-months apart, during which a complete medical evaluation was carried out and VAS, WOMAC and SF-12 questionnaires were completed. |
| Intervention type | Other |
| Primary outcome measure | Evaluation of the clinical benefit of an educational intervention for primary care physicians, proposing a proactive approach to care (defined as a focus on updated treatment recommendations) in patients with arthritis. The primary outcome was measured by comparing results from visit 1 with those of visit 2. |
| Secondary outcome measures | 1. Clinical characteristics, and progression of pain and functional capacity, in patients with knee and/or hip OA in Primary Care practice 2. identification of additional factors related with clinical inertia that, when modified, could result in clinical benefit for the patient 3. Description of characteristics of usual clinical practice carried out by primary care physicians |
| Overall study start date | 01/10/2007 |
| Completion date | 30/06/2008 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | Both |
| Target number of participants | 1,925 Primary Care Physicians |
| Key inclusion criteria | Physicians: 1. Belong to reselected Primary Care health centre 2. Have a daily clinical activity 3. Able to demonstrate a permanency up to 9 months in a clinical job 4. Commitment to follow all study criteria and recommendations Patients: 1. Known diagnosis of hip and/or knee osteoarthritis fulfilling American College of Rheumatology (ACR) criteria. 2. Selected by physician (study subject) and gives informed consent to participate in this trial. |
| Key exclusion criteria | Physicians: 1. Unable to ensure job stability at Primary Care health centre over 9 months 2. Does not accept study criteria and recommendations 3. Already involved in improvement effort programs regarding clinical support for patients affected by joint disease Patients: 1. Clinical antecedents of actual arthritic disease with prosthesis implanted 2. Arthritic disease involving exclusively or predominantly the spine (all locations) or upper limbs 3. Severe concomitant pathology with a short term life expectancy 4. Existence of non-arthritic rheumatic condition (fibromyalgia, rheumatoid arthritis, psoriasis, collagen diseases) 5. Psychological or sensorial impairment that prevents study participation 6. Existence of any absolute contraindication for anti-arthritic medications (Non-Steroidal Anti-Inflammatory Drugs [NSAIDs], etc.) 7. Does not wish to participate 8. Potential surgical intervention (next 6 months) 9. Additionally, any patients considered by his/her physician to be clinically inappropriate for participation and clinical data collection in this study |
| Date of first enrolment | 01/10/2007 |
| Date of final enrolment | 30/06/2008 |
Locations
Countries of recruitment
- Spain
Study participating centre
Hospital Universitario 12 de Octubre
Madrid
28041
Spain
28041
Spain
Sponsor information
Spanish Society of Family Medicine and Community (Sociedad Española de Medicina de Familia y Comunitaria [SEMFYC]) (Spain)
Government
Government
Portaferrissa, 8
Barcelona
08002
Spain
| Phone | +93 (0)317 0333 |
|---|---|
| semfyc@semfyc.es | |
"ROR" |
https://ror.org/01hn8xm90 |
Funders
Funder type
Industry
Merck, Sharp & Dohme de España S.A. (Spain) - educational grant
No information available
Family and Community Spanish Medical Society (SEMFyC) (Spain)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
